CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020
Operating expenses:
Research and development	$ 47,529	$ 31,618
General and administrative	21,489	11,748
Total operating expenses	69,018	43,366
Loss from operations	(69,018)	(43,366)
Other income:
Interest income	119	29
Total other income	119	29
Net loss and comprehensive loss	(68,899)	(43,337)
Cumulative dividends on redeemable convertible preferred stock	(1,228)	(5,925)
Net loss attributable to common stockholders	$ (70,127)	$ (49,262)
Net loss per share attributable to common stockholders, basic and diluted	$ (2.10)	$ (230.57)
Weighted-average common shares outstanding, basic and diluted	33,433,214	213,658